Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
The objective of this study was to evaluate the efficacy of pulse Methyl Prednisolone in treatment of Bell’s Palsy and its tolerance and safety. Additionally, the adverse drug reactions were also studied. In this study, 32 patients with lower motor neuron facial palsy were studied over a period of one year. House Brackman grading system was used to assess their facial nerve function at the time of admission and discharge. Vitals were monitored and evaluation for signs of infection and psychosis was done daily during the hospital stay. Risk factor work up was done at the time of admission. Significant improvement was noted in the House Brackman scale at the time of discharge. Side effects were noted in the form of steroid induced hypertension, hyperglycemia and hypothyroidism. None of the patient developed infection or psychosis during the treatment period. Thus, we can conclude that pulse Methyl Prednisolone significantly improves the treatment outcomes in cases of Bell’s Palsy. Improvement in the House Brackman scale was noted at the time of discharge. Pulse methyl prednisolone was well tolerated however it was associated with adverse drug reactions. Most common reactions were steroid induced hyperglycemia, hypertension and hypothyroidism.
How to cite this article:
Prasanna Kasegaonka and Nikita Mahesh Talpallikar. Efficacy of Pulse Methyl Prednisolone in Treatment of Bell’s Palsy.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.2.309.315
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.2.309.315